Observer
  • Business
  • Art
  • Lifestyle
  • Culture
Newsletters
  • Business
    • Finance
    • Media
    • Technology
    • Policy
    • Wealth
    • Insights
    • Interviews
  • Arts
    • Art Fairs
    • Art Market
    • Art Reviews
    • Auctions
    • Galleries
    • Museums
    • Interviews
  • Culture
    • Theater
    • Opera
    • Dance
    • Film
    • Interviews
  • Lifestyle
    • Nightlife & Dining
    • Style
    • Travel
    • Gift Guides
    • Interviews
  • Power Index
    • Nightlife & Dining
    • Business of Art
    • A.I.
    • PR
  • About
    • About Observer
    • Advertise With Us
    • Reprints
Newsletters

biotech

Headshot of man in black jacket and white shirt, wearing glasses

This Startup Backed By OpenAI and the Jobs Family Is the Latest A.I. Drug Discovery Unicorn

Chai Discovery more than doubled its valuation to $1.3 billion after raising $130 million to advance A.I.-powered drug development.
By Alexandra Tremayne-Pengelly
Horse colt pictured jumping in field

Colossal Biosciences Acquires Pet Cloning Company to Advance De-Extinction Efforts

Colossal’s purchase of ViaGen, known for cloning pets of celebrities, bolsters the biotech firm’s tools for de-extinction and conservation.
By Alexandra Tremayne-Pengelly
An illustration of human DNA.

This Longevity Startup Is Bringing Anti-Aging Gene Therapy to Human Trials

The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the clock on aging.
By Raphael McMahon
Digital rendering of small bird standing on grassy beach

The $10B Startup Behind the Revived Dire Wolf Reports Another Breakthrough

By Alexandra Tremayne-Pengelly
Man in black blazer and white button up shirt

Sam Altman-Backed Startup Aims to Add 10 Years to Human Life Through Stem Cell Tech

By Alexandra Tremayne-Pengelly
Illustration of a futuristic biotech facility with DNA helix, atomic structure, and colorful buildings, symbolizing scientific innovation and corporate scale.

23andMe Has Found a Buyer—Here’s What Might Happen to Your Genetic Data

By Alexandra Tremayne-Pengelly
Illustration of a small person surrounded by oversized hands and floating pills, symbolizing the impact and control of artificial intelligence and pharmaceutical companies over drug development and patient outcomes.

How A.I. Is Disrupting Pharma: The High-Stakes Race to Revolutionize Drug Discovery

By Rachel Curry
In nature, fluorescent proteins are used by jellyfish as a defense mechanism.

This A.I. Startup Founded by Ex-Meta Researchers Could Change Biology Forever

By Sissi Cao
White letters spelling out Amgen attached to brick wall

Amgen and CEO Robert Bradway Sued for Hiding $10.7 Billion Tax Bill from Investors

By Alexandra Tremayne-Pengelly

This Maye Musk-Approved Supplement Aims to Combat Aging at Cell Level

By Sissi Cao
Two men in blazers sit on grey couches on panel

Elon Musk’s Old Pals Invest in Neuralink to Fund Testing Brain Chips in Humans

By Sissi Cao

UBiome CEOs Resign From Biotech Startup Amid FBI Investigation

By Gabriela Barkho
Sunny Balwani

Former Theranos COO Sunny Balwani Prepares to Fight Fraud Charges

By Gabriela Barkho

6 Billionaires Whose Fear of Death Is Fueling a Boom In Biotech Startups

By Sissi Cao

V.C. Firm Names Robot To Board of Directors

By Jordyn Taylor

New Biometric T-Shirt Makes Fitbit Seem Like a Child's Toy

By Jack Smith IV

Boston Wants Everyone to Know New York Startups Aren’t So Special, Okay

By Kelly Faircloth
May some day lead to new forms of photo sharing.

NYU Chemists Create Some Crazy Molecule We Don’t Understand

By Ben Popper
"You'll fund my mobile app? Terrific!"

Does New York Tech Need More (Industry) Diversity?

By Ben Popper
  • ARTS
    • Art Fairs
    • Art Market
    • Art Reviews
    • Auctions
    • Galleries
    • Museums
  • BUSINESS
    • Energy
    • Finance
    • Media
    • Policy
    • Technology
    • Climate
  • CULTURE
    • Books
    • Dance
    • Film
    • Opera
    • Theater
  • LIFESTYLE
    • Autos
    • Hotels
    • Nightlife & Dining
    • Restaurants
    • Style
    • Travel
  • WEALTH
    • Billionaires
    • Parties
    • Philanthropy
    • Real Estate
  • EXPERT INSIGHTS
    • A.I. Experts
    • Art Market Experts
    • Climate Experts
    • Finance Experts
  • POWER LISTS
    • PR Power List
    • Nightlife & Dining
    • Business of Art
    • A.I. Power List
  • INTERVIEWS
    • Art World
    • Business Leaders
    • Tastemakers
    • Entertainers
  • ABOUT
  • ADVERTISE
  • CONTACT
  • NEWSLETTERS
  • RSS FEEDS
  • SITEMAP
  • TERMS
  • PRIVACY
  • REPRINTS
  • Privacy
  • Terms
  • Cookie Settings
  • Do not sell my data
Powered by WordPress VIP

We noticed you're using an ad blocker.

We get it: you like to have control of your own internet experience.
But advertising revenue helps support our journalism.

To read our full stories, please turn off your ad blocker.
We'd really appreciate it.

How Do I Whitelist Observer?

How Do I Whitelist Observer?

Below are steps you can take in order to whitelist Observer.com on your browser:

For Adblock:

Click the AdBlock button on your browser and select Don't run on pages on this domain.

For Adblock Plus on Google Chrome:

Click the AdBlock Plus button on your browser and select Enabled on this site.

For Adblock Plus on Firefox:

Click the AdBlock Plus button on your browser and select Disable on Observer.com.

Then Reload the Page